Recap: CVS Health Q2 Earnings

Shares of CVS Health CVS rose 4.6% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share increased 39.68% year over year to $2.64, which beat the estimate of $1.92.

Revenue of $65,341,000,000 up by 3.01% year over year, which beat the estimate of $64,180,000,000.

Looking Ahead

The upcoming fiscal year's EPS expected to be between $7.14 and $7.27.

Conference Call Details

Date: Aug 05, 2020

Time: 08:00 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg30.jsp&referrer=https%3A%2F%2Finvestors.cvshealth.com%2Finvestors%2Fevents-and-presentations%2Fdefault.aspx&eventid=2465869&sessionid=1&key=B0666A1ECCC099A4FEB630C3B6845C0D&regTag=&sourcepage=register

Technicals

52-week high: $77.03

52-week low: $52.04

Price action over last quarter: Up 10.66%

Company Overview

CVS Health Corp provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing about 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with about 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.